Journal article
Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada
Abstract
OBJECTIVE: This study aimed to evaluate palivizumab (PVZ) use, trends in indications, and outcomes of respiratory illness hospitalizations (RIH) and respiratory syncytial virus hospitalizations (RSVH).
STUDY DESIGN: It involves a large, Canadian prospective (2005-2017) observational multicenter study of children at high risk for RSV infection.
Authors
Mitchell I; Li A; Bjornson CL; Lanctot KL; Paes BA; investigators TC
Journal
American Journal of Perinatology, Vol. 39, No. 15, pp. 1668–1677
Publisher
Thieme
Publication Date
November 2022
DOI
10.1055/s-0041-1725146
ISSN
0735-1631